X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3885) 3885
Publication (410) 410
Report (121) 121
Book Review (110) 110
Book Chapter (46) 46
Newspaper Article (42) 42
Book / eBook (18) 18
Magazine Article (8) 8
Conference Proceeding (6) 6
Dissertation (6) 6
Reference (5) 5
Data Set (2) 2
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2089) 2089
humans (1812) 1812
index medicus (1734) 1734
male (1658) 1658
rats (1090) 1090
female (902) 902
sodium (765) 765
pharmacology & pharmacy (714) 714
physiology (574) 574
neurosciences (503) 503
rats, sprague-dawley (503) 503
middle aged (459) 459
adult (435) 435
dose-response relationship, drug (434) 434
hypertension (420) 420
mice (392) 392
research (381) 381
cardiac & cardiovascular systems (351) 351
blood pressure - drug effects (345) 345
rodents (340) 340
sodium channel blockers - pharmacology (338) 338
aged (334) 334
drugs (311) 311
medicine (309) 309
sodium channels (307) 307
hypertension - drug therapy (299) 299
time factors (296) 296
sodium - metabolism (277) 277
blood pressure (273) 273
research article (272) 272
multidisciplinary sciences (266) 266
disease models, animal (262) 262
article (257) 257
calcium channel blockers - pharmacology (257) 257
rats, wistar (257) 257
peripheral vascular disease (255) 255
neurons (254) 254
treatment outcome (243) 243
calcium channel blockers - therapeutic use (240) 240
health aspects (238) 238
pain (228) 228
physiological aspects (225) 225
risk factors (225) 225
analysis (218) 218
calcium - metabolism (216) 216
clinical neurology (215) 215
electrophysiology (214) 214
science (210) 210
care and treatment (204) 204
sodium channels - metabolism (204) 204
blood-pressure (203) 203
calcium (203) 203
electrocardiography (203) 203
calcium channel blockers - administration & dosage (200) 200
in vitro techniques (200) 200
ion channels (200) 200
sodium channel blockers - administration & dosage (198) 198
rat (192) 192
drug therapy (190) 190
patch-clamp techniques (187) 187
inhibition (184) 184
pharmacology (184) 184
hypertension - physiopathology (183) 183
drug therapy, combination (181) 181
proteins (180) 180
heart (172) 172
tetrodotoxin - pharmacology (172) 172
urology & nephrology (171) 171
antihypertensive agents - therapeutic use (170) 170
cells, cultured (168) 168
dosage and administration (168) 168
expression (165) 165
cell biology (163) 163
sodium channels - drug effects (163) 163
neuropathic pain (162) 162
diuretics (161) 161
sodium channel blockers (160) 160
neurons - drug effects (156) 156
sodium-channels (155) 155
action potentials - drug effects (154) 154
review (154) 154
sodium channel blockers - therapeutic use (152) 152
medicine, general & internal (151) 151
biochemistry & molecular biology (149) 149
activation (148) 148
amiloride - pharmacology (148) 148
mutation (146) 146
potassium (145) 145
double-blind (144) 144
studies (142) 142
anesthesiology (141) 141
biology (141) 141
brain (140) 140
channels (140) 140
toxicology (138) 138
cells (137) 137
heart rate - drug effects (134) 134
epilepsy (133) 133
lidocaine (132) 132
arrhythmia (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4043) 4043
German (21) 21
Japanese (16) 16
Russian (12) 12
French (7) 7
Swedish (6) 6
Italian (4) 4
Spanish (4) 4
Lithuanian (3) 3
Hungarian (2) 2
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 05/2007, Volume 104, Issue 20, pp. 8520 - 8525
Journal Article
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Clinical trials | Family medical history | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Fatal | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 9, pp. 882 - 887.e1
Abstract Objective Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary... 
Internal Medicine | Adherence | Prevention | Cardiovascular disease | PERSISTENCE | ACUTE CORONARY SYNDROMES | CONVERTING ENZYME-INHIBITORS | SECONDARY PREVENTION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | ACUTE MYOCARDIAL-INFARCTION | BETA-BLOCKERS | MEDICATION ADHERENCE | ARTERY-DISEASE | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence - statistics & numerical data | Cardiovascular Agents - administration & dosage | Age Factors | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Antihypertensive Agents - administration & dosage | Secondary Prevention - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Aspirin - administration & dosage | Drug Prescriptions - statistics & numerical data | Self Administration | Time Factors | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Primary Prevention - methods | Sodium Chloride Symporter Inhibitors - administration & dosage | Myocardial Infarction - prevention & control | Adrenergic beta-Antagonists - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Research | Patient compliance | Coronary heart disease | Drugs | Myocardial infarction | Aspirin | Side effects | Enzyme inhibitors | Risk reduction | Age | Statins
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2016, Volume 15, Issue 3, pp. 259 - 269
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 04/2017, Volume 114, Issue 14, pp. 3750 - 3755
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2012, Volume 56, Issue 9, pp. 4793 - 4799
Journal Article